599 results on '"Lassau, N."'
Search Results
2. Artificial intelligence solution to classify pulmonary nodules on CT
3. Artificial intelligence to predict clinical disability in patients with multiple sclerosis using FLAIR MRI
4. Abdominal musculature segmentation and surface prediction from CT using deep learning for sarcopenia assessment
5. Diagnosis of focal liver lesions from ultrasound using deep learning
6. Kidney cortex segmentation in 2D CT with U-Nets ensemble aggregation
7. Five simultaneous artificial intelligence data challenges on ultrasound, CT, and MRI
8. 6O Subcutaneous fat mass predicts progression-free survival in patients treated with antibody drug conjugates in early phase clinical trials
9. Selection of an early biomarker for vascular normalization using dynamic contrast-enhanced ultrasonography to predict outcomes of metastatic patients treated with bevacizumab
10. Actualisation des recommandations de prise en charge du mélanome stades I à III
11. Évaluation de l’échographie moléculaire au BR55 dans la mesure de l’expression vasculaire de VEGFR-2 dans un modèle PDX de carcinome rénal à cellules claires
12. Better than RECIST and faster than iRECIST: Defining the immunotherapy progression decision score to better manage progressive tumors on immunotherapy
13. Sequential research-related biopsies in phase I trials: acceptance, feasibility and safety
14. 1824P Sarcopenia in advanced non-small cell lung cancer (NSCLC): Clinical impact and its biological correlates
15. 110P 13-plex non-invasive genotyping in HPV related cancers in the MOSCATO trial
16. Cancer du rein : quels sont les critères pour juger de l’échec d’un traitement anti-angiogénique ? À propos d’un cas
17. Détection des lésions hépatiques malignes en échographie de contraste
18. Évaluation de l’angiogénèse tumorale à l’aide de l’échographie de contraste
19. Évaluation précoce des traitements anti-angiogéniques par échographie dynamique de contraste
20. Où en est l’échographie de contraste ?
21. Incorporating radiomics into clinical trials: expert consensus endorsed by the European Society of Radiology on considerations for data-driven compared to biologically driven quantitative biomarkers (Jan , 10.1007/s00330-020-07598-8, 2021)
22. Incorporating radiomics into clinical trials: expert consensus on considerations for data-driven compared to biologically driven quantitative biomarkers
23. Prolonged SARS-CoV-2 RNA virus shedding and lymphopenia are hallmarks of COVID-19 in cancer patients with poor prognosis
24. Comparison Between the Minimum Margin Defined on Preoperative Imaging and the Final Surgical Margin After Hepatectomy for Cancer: How to Manage It?
25. Dynamic assessment of antiangiogenic therapy by monitoring both tumoral vascularization and tissue degeneration
26. 142P Correlating total tumor volume on CT-Scan and liquid biopsy ctDNA in 1017 patients with metastatic cancer: A novel study
27. 1022MO Predicting overall survival of patients with melanoma and NSCLC treated with immunotherapy using AI combining total tumor volume and tumor heterogeneity on CT-Scans
28. 630P Determining a prognostic score using imaging to assess the benefit of combo anti-PD1 + anti-CTL4 vs anti-PD1 in patients with metastatic MSI/dMMR colorectal cancer (mCRC MSI)
29. Incorporating radiomics into clinical trials: expert consensus endorsed by the European Society of Radiology on considerations for data-driven compared to biologically driven quantitative biomarkers
30. Incorporating radiomics into clinical trials: expert consensus on considerations for data-driven compared to biologically driven quantitative biomarkers
31. Impact of Surgery on Advanced Gastrointestinal Stromal Tumors (GIST) in the Imatinib Era
32. L'échographie de contraste: un nouvel outil d'évaluation des thérapies ciblées
33. Full kringles of plasminogen (aa 1–566) mediate complete regression of human MDA-MB-231 breast tumor xenografted in nude mice
34. Incidence of Unsuspected and Treatable Metastatic Disease Associated With Operable Colorectal Liver Metastases Discovered Only at Laparotomy (and Not Treated When Performing Percutaneous Radiofrequency Ablation)
35. Traitement personnalisé selon l’imagerie fonctionnelle
36. Ultrasons
37. P-131 Evaluation of predictive factors of toxicity of chemotherapy with FOLFIRINOX in patients treated for pancreatic adenocarcinoma
38. Transfer of the murine interleukin-12 gene in vivo by a Semliki Forest virus vector induces B16 tumor regression through inhibition of tumor blood vessel formation monitored by Doppler ultrasonography
39. Artificial intelligence to predict clinical disability in patients with multiple sclerosis using FLAIR MRI
40. Long-term recurrences of jaw osteoradionecrosis after apparent healing with the PENTOCLO protocol
41. Fine needle aspiration cytology of oxyphilic parathyroid hyperplasia
42. Sunitinib efficacy in the treatment of metastatic skin adnexal carcinomas: report of two patients with hidradenocarcinoma and trichoblastic carcinoma
43. Limb salvage with isolated perfusion for soft tissue sarcoma: could less TNF-α be better?
44. Doppler US with perfusion software and contrast medium injection in the early evaluation of isolated limb perfusion of limb sarcomas: prospective study of 49 cases
45. Validation d’un banc hydrodynamique pour la caractérisation de produits de contraste ultrasonores (PCUS)
46. Portal vein thrombosis during antineoplastic chemotherapy in children: Report of five cases and review of the literature
47. Évaluation fonctionnelle et précoce des traitements en cancérologie : intérêt des produits de contraste ultrasonores
48. Phase II trial of thalidomide in renal-cell carcinoma
49. Thalidomide and Venous Thrombosis
50. 127P Better than RECIST and faster than iRECIST: Defining the immunotherapy progression decision score to better manage progressive tumors on immunotherapy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.